科学研究
报告题目：Learning from Failure: The Role of Disclosure on Innovation
报告人：王梦晗
报告时间：2026年5月6日（周三）13:00-14:10
报告地点：劝学楼245
主办单位：东北财经大学会计学院 辽宁省资本市场财务与会计研究生创新与学术交流中心
【报告摘要】
This paper examines how the disclosure of failed R&D outcomes shapes future innovation. I use an exogenous policy change that expanded the dissemination of failure information from clinical trials to study this trade-off. The number of new trials initiated increased following the policy change. The increase is driven primarily by incremental innovations on existing drugs rather than developments of new drugs, as failure disclosure provides more information on previously tested drugs but not on new chemical compounds. Consistent with the knowledge spillover effect, trial sponsors benefit more in medical fields where they had less internal expertise prior to the policy change. Despite the proprietary costs for disclosing entities, my findings support that the positive externality of mandatory failure disclosure outweighs its costs in the short run.
【报告人简介】
王梦晗，香港大学金融博士生，曾赴波士顿学院访问，在NBER, AFA, FMA, NFA等国际会议上报告论文，并获FMA公司金融最佳论文提名，曾担任《Journal of Accounting, Auditing & Finance》特邀审稿人。
【特别提醒】
未经论文作者和主办方允许，严禁将讲座内容录制并公开传播，违者将有可能被追究法律责任。
